Beacon Biomedical
About Beacon Biomedical
Beacon Biomedical is a biotech company, focuses on developing and commercializing waived tests for earlier cancer detection. It aims to save as many lives as possible by providing easy, accurate and affordable blood tests for earlier cancer detection. It developed test (LDT) solutions are developed for healthcare practitioners and individuals alike and our intended to be used as a screening test for the presence of undiagnosed cancer. They are specifically designed for those who are unwilling or unable to participate in cancer screening using current procedures and tests. It was founded in 2014 and is headquartered in Phoenix, Arizona.
Company Metrics
- Employees: 1-10
- Monthly Visits: None
- Tech Stack: 10 active products
Financial Information
- Estimated Revenue: $1M to $10M
- Total Funding: 391648 USD
- Last Funding: 366648 USD (Seed)
- Funding Status: Seed
Technology Stack
Beacon Biomedical actively uses 10 products in their tech stack.
Market Presence
Industries: Biotechnology, Health Care, Health Diagnostics
Headquarters: Phoenix, Arizona, United States